Evidence map›Paper›PMID 30158513›Full record

ReviewThe American journal of case reports2018

Double-Hit Lymphoma (MYC and BCL6) with Involvement of Skull and Adnexal Lesions: A Case Report and a Review of the Literature.

Hamza Minhas, Cherif Abdelmalek, Marium Khan, James E O'Donnell, Vladimir Gotlieb, Jen Chin Wang

Open access · hybridAbstract readCase ReportsReview
In one paragraph

Review in The American journal of case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hamza MinhasDivision of Hematology/Oncology, Brookdale Hospital Medical Center, Brooklyn, NY, USA.
Cherif AbdelmalekDivision of Hematology/Oncology, Brookdale Hospital Medical Center, Brooklyn, NY, USA.
Marium KhanDepartment of Internal Medicine, Brookdale Hospital Medical Center, Brooklyn, NY, USA.
James E O'DonnellDepartment of Pathology, Brookdale Hospital Medical Center, Brooklyn, NY, USA.
Vladimir GotliebDivision of Hematology/Oncology, Brookdale Hospital Medical Center, Brooklyn, NY, USA.
Jen Chin WangDivision of Hematology/Oncology, Brookdale Hospital Medical Center, Brooklyn, NY, USA.
Brookdale University Hospital and Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Double-hit lymphomas (DHL) belong to a category of very aggressive lymphomas characterized by MYC translocation and either BCL2, or less commonly, BCL6 translocations. Those with BCL6 translocations have a predilection for rare extranodal sites such as the gastrointestinal tract, nasopharynx, and tonsils. Involvement of the skull and adnexal structures is rare. Here we report a case of a young female with both skull and adnexal involvement. CASE REPORT A 20-year-old female who presented with hypercalcemia was found to have adnexal, skull, and jaw masses. Workup revealed a stage IV high grade B-cell lymphoma (HGBL) with MYC and BCL6 rearrangements. She was subsequently treated with R-EPOCH and attained complete remission 9 months after her initial presentation. To the best of our knowledge, our patient represents the first reported case of skull and adnexal involvement in HGBL with MYC and BCL6 rearrangement. CONCLUSIONS Rare extranodal presentations of HGBL with MYC and BCL6 rearrangement should be considered in the differential diagnosis of masses found in unusual sites such as the skull and adnexa. Due to their aggressive nature, early and prompt recognition of these lymphomas is essential for timely administration of appropriate therapy.

Indexed as

Burkitt LymphomaFemaleGenes, mycHumansLymphoma, B-CellProto-Oncogene Proteins c-bcl-6Skull NeoplasmsTranslocation, GeneticYoung AdultBCL6 protein, humanProto-Oncogene Proteins c-bcl-6

Identifiers

PMID30158513
PMCPMC6128191
OpenAlexW2888837206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.